Abstract

CLC Number:

R994.11

Add to citation manager EndNote|Ris|BibTeX

URL: https://zgywjj.magtechjournal.com/EN/

https://zgywjj.magtechjournal.com/EN/Y2017/V14/I7/446

[1] 吴铁成, 邵永孚, 贾志丹, 等. OK432（力尔凡）临床应用研究进展[J]. 中国肿瘤生物治疗杂志, 1999, 6(3): 227．
[2] 赵殿银, 刘胜, 娟龙莉, 等. 力尔凡致过敏性休克2例[J]. 天津护理, 2003, 11(2): 81.
[3] 段露芬, 武新安, 王松原, 等.甘露聚糖肽注射液致不良反应1例[J]. 中国医院药学杂志2014, 34(21): 1878-1879.
[4] 张景文, 杨梅珍. 甘露聚糖肽致严重过敏反应相关因素分析[J]. 中国医院药学杂志2014, 34(11): 946-949.
[5] 杨秀萍, 吴峥嵘. 甘露聚糖肽致速发型过敏反应1例[J]. 中国药物警戒, 2008, 5(5): 315-316.
[6] 李运景, 李雪芹. 甘露聚糖肽注射液致不良反应文献分析[J]. 中国药房, 2011, 22(10):919-921.
[7] 金淑君, 赵艳. 甘露聚糖肽注射液致过敏性休克[J]. 中国药物应用与监测, 2014, 11(3)：189-190.
[8] 司可意, 王利杰. 12例静脉滴注甘露聚糖肽致不良反应报告[J]. 中国医院用药评价与分析, 2017, 17(1): 116-118.
[9] 张传洲, 王腾, 刘黎莎, 等. 注射用甘露聚糖肽致严重过敏性休克1例[J]. 药品评价, 2015, 12(22): 42-43.
[10] 江慧星, 文晓柯, 肖凯. 甘露聚糖肽注射液致过敏性休克1例的启示[J]. 实用预防医学, 2012, 19(5): 734,741.
[11] 邓彩霞,李文峰.甘露聚糖肽注射液致过敏性休克1例分析[J].中国药师, 2009, 12(12): 1805-1806.
[12] 乔逸, 徐焕春, 廖悠悠, 等. 甘露聚糖肽注射液致过敏性休克2例[J]. 抗感染药学, 2015, 12(1): 76-78.
[13] 殷 , 罗艳丽. 甘露聚糖肽注射液致速发型过敏性休克的抢救体会一例[J]. 华西医学, 2016, 31(5): 996-997.
[14] 李波, 姜黎, 尚天琼, 等.甘露聚糖肽注射液致心前区剧烈胀痛[J]. 中国现代应用药学, 2015, 32(4): 643.
[15] 刘小光, 徐柳新, 陈伟. 疑似甘露聚糖肽注射液致死亡1例[J]. 中国药物警戒, 2014, 11(4): 251-252.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

[1]	LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850.
[2]	WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855.
[3]	XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862.
[4]	CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875.
[5]	CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882.
[6]	ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888.
[7]	SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895.
[8]	SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919.
[9]	YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923.
[10]	KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927.
[11]	LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932.
[12]	LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936.
[13]	ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940.
[14]	ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943.
[15]	CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. One Case of Acute Withdrawal Syndrome Caused by Naloxone [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946.